Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Europa
Chr. Hansen Holding
Nieuws
Christian Hansen
CHR
COP
: CHR
| ISIN: DK0060227585
30/01/2024
549,60 DKK
(-0,61%)
(-0,61%)
30/01/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
29 januari 2024 ·
Completion of the combination between Novozymes and Chr. Hansen
· Persbericht
26 januari 2024 ·
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
· Persbericht
20 december 2023 ·
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
· Persbericht
19 december 2023 ·
Major shareholder announcement from Burlington Loan Management DAC
· Persbericht
12 december 2023 ·
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained
· Persbericht
20 november 2023 ·
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.
· Persbericht
2 november 2023 ·
Managers' Transaction
· Persbericht
13 oktober 2023 ·
Managers' Transactions
· Persbericht
12 oktober 2023 ·
Chr. Hansen Holding A/S Interim Report Q4 2022/23
· Persbericht
10 oktober 2023 ·
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
· Persbericht
27 september 2023 ·
Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP
· Persbericht
4 september 2023 ·
Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion
· Persbericht
6 juli 2023 ·
Chr. Hansen Holding A/S Interim Report Q3 2022/23
· Persbericht
13 april 2023 ·
Chr. Hansen Holding A/S Interim Report Q2 2022/23
· Persbericht
30 maart 2023 ·
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
· Persbericht
30 maart 2023 ·
Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S
· Persbericht
30 maart 2023 ·
Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders
· Persbericht
28 maart 2023 ·
Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion
· Persbericht
8 maart 2023 ·
Notice to convene Extraordinary General Meeting
· Persbericht
8 maart 2023 ·
Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe